Chikungunya Virus Antibodies
Private Chikungunya Virus Antibodies test in London for £422.99, measuring one arboviral antibody marker with results expected in around 10 days.
Turnaround time
10 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Chikungunya Virus Antibodies
The Chikungunya Virus Antibodies blood test detects antibodies produced by the immune system following infection with chikungunya virus.
The test contains 1 biomarker: Chikungunya Virus Antibodies.
Chikungunya is an arthropod-borne virus transmitted primarily through bites from infected Aedes mosquitoes, including species that can also transmit Dengue and Zika viruses.
Transmission occurs in tropical and subtropical regions across parts of Africa, Asia, the Indian subcontinent, the Caribbean, Central America, South America and other areas where competent mosquito vectors are established.
Acute chikungunya classically causes sudden fever and significant joint pain.
Headache, muscle pain, joint swelling, fatigue and rash can also occur.
The joint symptoms can be particularly prominent and may affect several joints simultaneously.
While many people recover from the acute illness, some experience persistent or recurrent joint pain for weeks or months, and occasionally longer.
Laboratory test choice depends on how long it has been since symptoms began.
During the early viraemic phase, molecular testing such as PCR can be more useful because the virus itself may be detectable before the antibody response is established.
Antibody testing becomes increasingly useful once the immune system has had time to produce measurable antibodies.
Testing too early can therefore produce a negative antibody result despite genuine infection.
IgM antibodies generally develop earlier and may persist for some time after acute illness.
IgG develops later and can remain detectable much longer.
Interpretation therefore depends on symptom timing, travel history and the exact antibody methodology used.
Other mosquito-borne infections can cause overlapping symptoms, particularly Dengue and Zika.
Travel history and clinical details should accompany specialist Chikungunya testing.
What Does the Chikungunya Virus Antibodies Test Check?
This test measures 1 biomarker.
Chikungunya Virus Antibodies
Detects an antibody response associated with Chikungunya virus infection. Interpretation depends on the interval from symptom onset, travel history and stage of the immune response.
Who May Benefit From the Chikungunya Virus Antibodies Test?
Testing may be appropriate after compatible illness and travel or residence in an area where Chikungunya transmission occurs.
People who developed fever and prominent joint pain after tropical travel - This clinical combination is characteristic of Chikungunya but requires appropriate laboratory and clinical assessment.
People with persistent joint pain after a mosquito-borne febrile illness - Arthralgia can persist after the acute phase of Chikungunya.
People who developed rash, fever and joint swelling after relevant travel - This symptom combination can be compatible with Chikungunya infection.
People with substantial mosquito exposure in an affected region - Epidemiological exposure is important when determining whether testing is appropriate.
People tested after the early PCR window - Antibody testing becomes more useful once the immune response has developed.
People with a previous inconclusive Chikungunya test - Repeat serology may sometimes demonstrate an evolving antibody response.
People undergoing specialist post-travel assessment - Chikungunya may be considered alongside Dengue, Zika, Malaria and other travel-related infections.
People with persistent unexplained arthralgia following travel - Previous Chikungunya infection may be one consideration where the exposure history is appropriate.
People specifically referred for Chikungunya serology - Clinical and travel information should accompany the request.
How to Prepare
Testing very early can produce a negative antibody result before antibodies have reached detectable levels.
The current laboratory also requires relevant clinical and travel history to support appropriate specialist interpretation.
Symptoms and Reasons to Consider the Chikungunya Virus Antibodies Test
Chikungunya commonly causes an acute febrile illness with prominent joint symptoms.
Sudden fever after travel to a Chikungunya-risk region - Acute fever is one of the characteristic presenting features.
Severe pain affecting several joints - Polyarthralgia is particularly characteristic of Chikungunya infection.
Joint swelling - Inflammatory joint symptoms can accompany the acute illness.
Persistent joint stiffness after the fever has resolved - Musculoskeletal symptoms can continue beyond the initial infection.
Skin rash - A maculopapular rash can occur during acute Chikungunya.
Headache - Headache is a commonly reported systemic symptom.
Muscle aches - Generalised myalgia can accompany the acute febrile illness.
Marked fatigue following a mosquito-borne illness - Tiredness may persist during recovery.
Symptoms beginning after substantial mosquito exposure abroad - The travel and exposure history materially affects the likelihood of Chikungunya.
These symptoms overlap substantially with Dengue, Zika and other viral infections, and fever after tropical travel also requires consideration of Malaria where relevant.
Anyone who is significantly unwell after travel, particularly with high fever, bleeding, severe weakness, confusion, breathing difficulty or possible Malaria exposure, should obtain prompt clinical assessment.
How to Book Your Chikungunya Virus Antibodies Test
Booking your Chikungunya Virus Antibodies test with London Blood Tests is straightforward.
Choose the Chikungunya Virus Antibodies
Select the specialist Chikungunya serology test.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy depending on availability.
Attend your appointment
A trained healthcare professional collects the venous blood sample and relevant travel history should be provided.
Laboratory analysis
Your serum undergoes specialist analysis for Chikungunya Virus Antibodies.
Receive your results securely
Your authorised serology report is delivered securely for interpretation alongside symptom timing and travel history.
When Will I Receive My Results?
The current specialist laboratory turnaround for Chikungunya Virus Antibodies is approximately 10 days after your sample reaches the laboratory.
This is a specialist virology serology assay and is not processed on the same rapid schedule as routine biochemical markers.
The laboratory also requires relevant clinical history and travel history, which help place the antibody result in its proper diagnostic context.
Once the sample has been received, specialist antibody analysis, quality-control procedures and laboratory authorisation must be completed before the report is released.
If the timing of the sample makes the result inconclusive or further arbovirus testing is requested, the overall diagnostic process can take longer than the initial 10-day turnaround.
Understanding Your Results
A negative antibody result means a significant Chikungunya antibody response was not detected by the laboratory assay.
If testing occurred very early after symptom onset, this does not completely exclude infection because antibodies may not yet have developed.
A positive result provides evidence of an immune response to Chikungunya virus.
The interpretation depends on the antibody pattern, laboratory methodology and time since symptoms began.
IgM generally develops earlier and can support relatively recent infection in the appropriate context.
IgG tends to develop later and can remain detectable after the acute infection has resolved.
Serology does not determine how severe the infection was and does not prove that persistent joint pain is currently being caused by active viral replication.
Cross-reactivity and overlapping epidemiology with other arboviruses mean travel history remains important.
Where the illness began very recently, molecular testing may have been more appropriate than serology during the initial viraemic phase.
Why Book With London Blood Tests?
Private Chikungunya testing in London - Access specialist arboviral serology privately.
Travel-focused assessment - Results can be interpreted alongside relevant geographical exposure.
Useful after the earliest stage of infection - Antibody testing becomes increasingly informative once the immune response develops.
Relevant to persistent joint symptoms - Chikungunya is particularly associated with prolonged arthralgia in some people.
Specialist virology analysis - Your sample undergoes dedicated antibody testing.
Clinic and home collection options - Professional phlebotomy can be arranged.
Secure reporting - Receive your authorised specialist result securely.
Clear pricing - The Chikungunya Virus Antibodies test costs £422.99.
Private Chikungunya Virus Antibodies Blood Test in London
London Blood Tests provides private Chikungunya Virus Antibodies testing in London for people requiring specialist investigation after relevant travel or mosquito exposure.
The test costs £422.99 and measures one biomarker: Chikungunya Virus Antibodies.
Results are expected approximately 10 days after laboratory receipt.
Travel and clinical history are particularly important because symptoms overlap with several other tropical infections.